News
Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...
Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co.
NeuroX recently acquired the assets and operations of MindMaze, a world-renowned leader in evidence-based neurotherapeutic solutions for neurological diseases and brain disordersBusiness combination ...
"This was primarily driven by 18% growth seen from the oncology portfolio, which has done well as a result of key drugs such ...
Amgen Inc. (NASDAQ:AMGN) is on the hunt for its next breakthrough drug— a common pursuit among pharmaceutical companies ...
Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company's swift and supersized $203 ...
Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...
In addition to telling time, smartwatches can track your steps, heart rate, blood pressure and sleeping patterns. Now, a smartwatch has helped search and rescue teams locate a ...
Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...
4d
Que.com on MSNAI in FDA Drug Approvals Sparks Controversy Over Fabricated Studies
In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...
On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results